Coloplast A/S (CBHD) Stock Statistics & Valuation Metrics
Total Valuation
Coloplast A/S has a market cap or net worth of CHF 13.38B. The enterprise value is CHF 106.89B.
- Market Cap
- CHF 13.38B
- Enterprise Value
- CHF 106.89B
Share Statistics
Coloplast A/S has 210,200,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 210,200,000
- Owned by Insiders
- ―
- Owned by Institutions
- 16.83%
Financial Efficiency
Coloplast A/S’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 13.38%.
- Return on Equity (ROE)
- 0.28
- Return on Assets (ROA)
- 0.11
- Return on Invested Capital (ROIC)
- 13.38%
- Return on Capital Employed (ROCE)
- 0.19
- Revenue Per Employee
- 1.57M
- Profits Per Employee
- 293.50K
- Employee Count
- 17,213
- Asset Turnover
- 0.56
- Inventory Turnover
- 2.60
Valuation Ratios
The current PE Ratio of Coloplast A/S is 35.03. Coloplast A/S’s PEG ratio is -15.27.
- PE Ratio
- 35.03
- PS Ratio
- 7.30
- PB Ratio
- 19.88
- Price to FCF
- 41.59
- Price to Operating Cash Flow
- 32.33
- PEG Ratio
- -15.27
Income Statement
In the last 12 months, Coloplast A/S had revenue of 27.03B and earned 5.05B in profits. Earnings per share was 22.46.
- Revenue
- 27.03B
- Gross Profit
- 17.48B
- Operating Income
- 7.32B
- Pretax Income
- 6.39B
- Net Income
- 5.05B
- EBITDA
- 8.57B
- Earnings Per Share (EPS)
- 22.46
Cash Flow
In the last 12 months, operating cash flow was 6.29B and capital expenditures -1.36B, giving a free cash flow of 4.92B billion.
- Operating Cash Flow
- 6.29B
- Free Cash Flow
- 4.92B
- Free Cash Flow per Share
- 18.65
Dividends & Yields
Coloplast A/S pays an annual dividend of ―, resulting in a dividend yield of 10.66%
- Dividend Per Share
- ―
- Dividend Yield
- 10.66%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.40%
- Earnings Yield
- 2.85%
Stock Price Statistics
- Beta
- -0.24
- 52-Week Price Change
- -46.65%
- 50-Day Moving Average
- 58.46
- 200-Day Moving Average
- 85.12
- Relative Strength Index (RSI)
- 43.82
- Average Volume (3m)
- 195
Important Dates
Coloplast A/S upcoming earnings date is Nov 03, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 18, 2026
- Next Earnings Date
- Nov 03, 2026
- Ex-Dividend Date
- ―
Financial Position
Coloplast A/S as a current ratio of 1.02, with Debt / Equity ratio of 126.12%
- Current Ratio
- 1.02
- Quick Ratio
- 0.66
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- 2.55
- Interest Coverage Ratio
- 8.30
Taxes
In the past 12 months, Coloplast A/S has paid 1.34B in taxes.
- Income Tax
- 1.34B
- Effective Tax Rate
- 0.21
Enterprise Valuation
Coloplast A/S EV to EBITDA ratio is 25.10, with an EV/FCF ratio of 46.20.
- EV to Sales
- 8.11
- EV to EBITDA
- 25.10
- EV to Free Cash Flow
- 46.20
- EV to Operating Cash Flow
- 35.92
Balance Sheet
Coloplast A/S has CHF 729.00M in cash and marketable securities with CHF 24.26B in debt, giving a net cash position of -CHF 23.54B billion.
- Cash & Marketable Securities
- CHF 729.00M
- Total Debt
- CHF 24.26B
- Net Cash
- -CHF 23.54B
- Net Cash Per Share
- -CHF 111.96
- Tangible Book Value Per Share
- CHF 75.16
Margins
Gross margin is 68.78%, with operating margin of 28.52%, and net profit margin of 20.84%.
- Gross Margin
- 68.78%
- Operating Margin
- 28.52%
- Pretax Margin
- 27.14%
- Net Profit Margin
- 20.84%
- EBITDA Margin
- 32.32%
- EBIT Margin
- 27.90%
Analyst Forecast
The average price target for Coloplast A/S is CHF 57.19, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- CHF 57.19
- Price Target Upside
- 2.25% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 1
- Revenue Growth Forecast
- 0.04%
- EPS Growth Forecast
- -33.25%
